Exactech Q2 Revenue Up 8% To $66.1 Million; Net Income Up 20% To $4.4 Million; Diluted EPS $0.31 Vs. $0.26

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced revenue of $66.1 million for the second quarter of 2016, an 8% increase from $61.5 million in the second quarter of 2015. On a constant currency basis, revenue was up 7%. Net income increased 20% to $4.4 million, or $0.31 per diluted share, compared to $3.7 million, or $0.26 per diluted share, in the same quarter a year ago. Second Quarter Segment Performance
MORE ON THIS TOPIC